1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow SYNB1020: new trials by email Literature Review of SYNB1020 trials Research Report on SYNB1020
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability and Pharmacodynamics of SYNB1020 SYNB1020, Placebo - Cirrhosis | Phase 1 / Phase 2 | Terminated | Synlogic | 23 | 2018-03-19 | 2021-05-13 |
| Safety and Tolerability of SYNB1020-CP-001 Placebo, SYNB1020 - Healthy Volunteer, Urea Cycle Disorder | Phase 1 | Completed | Synlogic | 52 | 2017-06-16 | 2021-05-12 |
Fibrosis (1) · Urea Cycle Disorders, Inborn (1)
Synlogic (2)
United States (2)